---
title: "《业绩》博富临置业全年亏损收窄至 2.16 亿元  末期息派 32 仙"
description: "博富临置业公布 9 月止财政年度业绩，收入录得 1.74 亿元，按年增加 3.8%。亏损由上年度 5.97 亿元，收窄至 2.16 亿元，每股亏损 1.96 元。末期息维持派 32 仙。"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/270027994.md"
published_at: "2025-12-17T14:37:25.000Z"
---

# 《业绩》博富临置业全年亏损收窄至 2.16 亿元  末期息派 32 仙

> 博富临置业公布 9 月止财政年度业绩，收入录得 1.74 亿元，按年增加 3.8%。亏损由上年度 5.97 亿元，收窄至 2.16 亿元，每股亏损 1.96 元。末期息维持派 32 仙。

博富临置业 (00225.HK) 公布 9 月止财政年度业绩，收入录得 1.74 亿元，按年增加 3.8%。亏损由上年度 5.97 亿元，收窄至 2.16 亿元，每股亏损 1.96 元。末期息维持派 32 仙。

### Related Stocks

- [00225.HK - 博富临置业](https://longbridge.com/zh-CN/quote/00225.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Pokfulam Development Company Limited Held Annual General Meeting | Pokfulam Development Company Limited held its Annual General Meeting on February 5, 2026, where shareholders approved al | [Link](https://longbridge.com/zh-CN/news/274953817.md) |
| Rich Goldman Expects Loss Of HK$10 Million For HY | Rich Goldman Holdings Ltd :EXPECTS LOSS OF HK$10 MILLION FOR HYEXPECTED HY RESULTS DUE TO REVERSAL OF IMPAIRMENT LOSS ON | [Link](https://longbridge.com/zh-CN/news/276043310.md) |
| CICC Reaffirms Their Buy Rating on Suzhou Ribo Life Science Co., Ltd. Class H (6938) | In a report released yesterday, from CICC maintained a Buy rating on Suzhou Ribo Life Science Co., Ltd. Class H, with a  | [Link](https://longbridge.com/zh-CN/news/276199846.md) |
| K-shaped vs. E-shaped economy: Are you falling behind without even knowing it? | Explore the difference between K-shaped and E-shaped economies and how they affect top earners, middle earners, and lowe | [Link](https://longbridge.com/zh-CN/news/276000967.md) |
| They Asked Middle-Class Americans Who Escaped Paycheck-To-Paycheck Living What Finally Worked. One Answer Kept Coming Up Again And Again | Middle-class Americans escaping paycheck-to-paycheck living attribute their success primarily to job hopping and elimina | [Link](https://longbridge.com/zh-CN/news/276075834.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。